No Data
No Data
Eyenovia Insiders Enjoying US$200k Appreciation On US$1.34m Investment
Eyenovia Shares Are Trading Higher. The Company Announced That It Commenced Activities With NovaBay Pharmaceuticals to Promote Eye Care Products to Ophthalmic Surgery Centers.
Eyenovia Shares Are Trading Higher. The Company Announced That It Commenced Activities With NovaBay Pharmaceuticals to Promote Eye Care Products to Ophthalmic Surgery Centers.
Eyenovia Announces Share Offering and Warrants Sale
NovaBay and Eyenovia Begin Co-Promotion of Eyecare Products to Ophthalmic Surgery Centers
NovaBay Pharmaceuticals, Inc. (NYSE:NBY), a company developing and commercializing high-quality eyecare products, and Eyenovia, Inc. (NASDAQ:EYEN), a commercial-stage ophthalmic company with two FDA-a
Eyenovia Prices $5M Registered Direct Offering Of 7,575,757 Shares And Warrants At $0.66 Per Share And Accompanying Warrant
Eyenovia Prices $5M Registered Direct Offering Of 7,575,757 Shares And Warrants At $0.66 Per Share And Accompanying Warrant
Express News | Eyenovia Announces Pricing of $5M Registered Direct Offering